- 英文名称
- Edoxaban impurity D
- 分子式
- C21H30ClN5O5
- 分子量
- 467.95
- 中文别名
- [(1R,2S,5S)-2-[[2-[(5-氯吡啶-2-基)氨基]-2-氧代乙酰基]氨基]-5-(二甲基氨基羰基)环己基]氨基甲酸叔丁酯; N1-(5-氯吡啶-2-基)-N2-((1S,2R,4S)-2-[(叔丁氧羰基)氨基]-4-[(二甲基氨基)羰基]环己基)乙二酰胺; 伊多塞班杂质1G; 伊多塞班杂质; 依杜沙班杂质D; 依多沙班杂质13(1S,2R,4S); 艾多沙班中间体; EthanediaMide Impurity D; N1-(5-chloropyridin-2-yl)-N2-((1S,2R,4S)-2-[(tert-Butoxycarbonyl)Amino]-4-[(dimethylamino)carbonyl]-cyclohexyl) oxalamide; tert-Butyl(1R,2S,5S)-2-({2-[(5-chloropyridin-2-yl)aMino]-2-oxoacetyl}aMino)-5-[(diMethylaMino)carbonyl]cyclohexyl-carbaMate; Edoxaban impurity 12/tert-Butyl [(1R,2S,5S)-2-[[2-[(5-chloropyridin-2-yl)amino]-2-oxoacetyl]amino]-5-(dimethylaminocarbonyl)cyclohexyl]carbamate; Edoxaban iMpurities 4; Edoxaban-4; Carbamic acid, n-[(1r,2s,5s)-2-[[2-[(5-chloro-2-pyridinyl) amino]-2-oxoacetyl]amino]-5-[(dimethylamino)carbonyl]cyclohexyl]-, 1,1-dimethylethyl ester; tert-butyl [(1R,2S,5S)-2-({[(5-chloropyridin-2-yl)amino](oxo)acetyl}amino)-5-(dimethylaminocarbonyl)cyclohexyl]carbamate; Carbamic acid, N-[(1R,2S,5S)-2-[[2-[(5-chloro-2-pyridinyl)amino]-1,2-dioxoethyl]amino]-5-[(dimethylamino)carbonyl]cyclohexyl]-, 1,1-dimethylethyl ester; tert-butyl (1R,2S,5S)-2-({2-[(5-chloropyridin-2-yl)amino]-2-oxoacetyl}amino)-5-(dimethylaminocarbonyl)cyclohexylcarbamate; t-butyl [(1R,2S,5S)-2-({[(5-chloropyridin-2-yl)amino](oxo)acetyl}amino)-5-(dimethylaminocarbonyl)cyclohexyl]carbamate; tert-butyl (1R,2S,5S)-2-({2-[(5-chloro-pyridin-2-yl)amino]-2-oxoacetyl}amino)-5-(dimethylaminocarbonyl)cyclohexylcarbamate; 2-Methyl-2-propanyl [(1R,2S,5S)-2-({[(5-chloro-2-pyridin-2-yl)amino](oxo)acetyl}amino)-5-(dimethylcarbamoyl)cyclohexyl]carbamate
- 用途
- 概述
依度沙班杂质D 是 Edoxaban 的一种杂质。Edoxaban (DU-176) 是一种选择性，有效和具有口服活性的 factor Xa (FXa) 抑制剂，对游离 FXa 和凝血酶原的 Ki 分别为 0.561 nM 和 2.98 nM。Edoxaban 是一种抗凝剂，可用于预防中风。
